You’ve read the miracle thread and the horror thread. A friend swears by it; a headline says it’ll wreck you. The clinic wants a card on file, the forum wants you in deeper, and a confident, machine-written “protocol” has an answer for everything — and you’re no closer to a decision.
That’s not your failure. That’s the noise doing its job. The Peptide Era is the map through it: an evidence-first guide that grades every claim about GLP-1s — semaglutide, tirzepatide, retatrutide, and what comes next — on a named Evidence Ladder, from large human trials down to a stranger’s anecdote, so you can tell what’s proven from what’s merely loud.
What’s inside
- What GLP-1 medicines actually do — and where the evidence quietly thins out.
- How to read a headline or a study without getting played.
- The real risks, and the overblown ones, told straight.
- Muscle, cravings, older age, the gray market, and what’s coming next.
- Where the honest answer is still “we don’t know” — said plainly.
How it’s different
No doses. No sourcing. No miracle cures — by design. Every claim is sourced. Every uncertainty is named out loud. There’s nothing here for sale but the book.
It’s for the overwhelmed person considering these medicines, already taking one, or watching someone they love decide. You won’t be handed an answer — you’ll walk in able to weigh one.